REGULATION of Eif2b by PHOSPHORYLATION

Total Page:16

File Type:pdf, Size:1020Kb

REGULATION of Eif2b by PHOSPHORYLATION REGULATION OF eIF2B BY PHOSPHORYLATION A thesis submitted to The University of Manchester for the degree of Doctor of Philosophy in the Faculty of Life Sciences 2013 REHANA KOUSAR Table of contents Table of figures .............................................................................................................. 5 Table of tables ................................................................................................................ 7 Abstract .......................................................................................................................... 8 Declaration ..................................................................................................................... 9 Copyright ..................................................................................................................... 10 Acknowledgements ...................................................................................................... 12 List of abbreviations .................................................................................................... 13 Communications .......................................................................................................... 15 1 Introduction .......................................................................................................... 17 1.1 Prokaryotic translation initiation ...................................................................... 18 1.2 Eukaryotic translation ...................................................................................... 21 1.2.1 Translation initiation ................................................................................ 21 1.2.2 IRES mediated translation initiation ........................................................ 27 1.2.3 CITE assisted translation initiation .......................................................... 28 1.2.4 Translation elongation ............................................................................. 29 1.2.5 Translation termination ............................................................................ 31 1.3 Targets of translational control ........................................................................ 32 1.3.1 Cis-acting elements and translation regulation ........................................ 33 1.3.2 Trans-acting factors and translation regulation ....................................... 37 1.4 Control of initiation factors activity by phosphorylation ................................. 38 1.5 eIF2: function, structure and control ................................................................ 39 1.5.1 Localization of eIF2 ................................................................................. 39 1.5.2 Role of eIF2 ............................................................................................. 40 1.5.3 Structure of eIF2 ...................................................................................... 40 1.5.4 eIF2 kinases ............................................................................................. 42 1.5.5 eIF2α(p) and expression of GCN4 ........................................................... 48 1.6 Target of Rapamycin pathway ......................................................................... 49 1.6.1 Structure of TOR ...................................................................................... 51 1.6.2 TOR complexes ....................................................................................... 51 1.6.3 Rapamycin sensitive TORC1 ................................................................... 52 1.6.4 Rapamycin insensitive TORC2 ................................................................ 57 1.7 eIF2B-GEF for eIF2 ......................................................................................... 59 1.7.1 Localization of eIF2B .............................................................................. 60 1.7.2 Subunit structure of eIF2B ....................................................................... 60 1.7.3 Mechanisms of eIF2B catalysed reaction ................................................ 65 1.7.4 Regulation of eIF2B activity .................................................................... 67 1.7.5 Mammalian eIF2B kinases ...................................................................... 68 1.7.6 eIF2B and Human Disease ....................................................................... 71 1.8 Introduction to current study ............................................................................ 72 1.8.1 The aims and objective(s) of the research ................................................ 73 1.8.2 Structure of thesis .................................................................................... 73 2 MATERIALS AND METHODS ......................................................................... 75 2.1 Yeast strains ..................................................................................................... 75 2.1.1 S. cerevisiae strains .................................................................................. 75 2.1.2 List of plasmids ........................................................................................ 77 2.2 Growth media ................................................................................................... 77 2.2.1 Yeast growth media ................................................................................. 77 Regulation of eIF2B by Phosphorylation 2 Table of contents 2.3 List of E. coli strains ........................................................................................ 80 2.3.1 Luria-Bertani medium for E. coli ............................................................. 80 2.4 S. cerevisiae strains growth and maintenance .................................................. 81 2.4.1 Strain maintenance ................................................................................... 81 2.4.2 Reviving the strains from -80˚C .............................................................. 81 2.5 DNA recombinant methods ............................................................................. 82 2.5.1 Plasmid DNA isolation from E. coli ........................................................ 82 2.5.2 Site directed mutagenesis ......................................................................... 82 2.5.3 Transformation of E. coli ......................................................................... 83 2.5.4 Restriction digestion ................................................................................ 85 2.5.5 Agarose gel electrophoresis ..................................................................... 85 2.5.6 DNA sequencing ...................................................................................... 86 2.5.7 Lithium acetate aided yeast transformation ............................................. 87 2.5.8 Plasmid shuffling ..................................................................................... 88 2.6 Growth assays .................................................................................................. 90 2.6.1 Yeast quantitative growth assays ............................................................. 90 2.7 Polysome profiling ........................................................................................... 93 2.7.1 Whole cells extract preparation ............................................................... 94 2.7.2 Sucrose density gradients preparation ..................................................... 95 2.7.3 Procedure of sucrose gradient sedimentation .......................................... 95 2.8 Biochemical methods ....................................................................................... 96 2.8.1 Cell lysis and protein extraction (small scale) ......................................... 96 2.8.2 Quantification of protein in whole cells extract-Bradford assay ............. 97 2.8.3 Purification of FLAG-tagged eIF2B ........................................................ 97 2.8.4 Dephosphorylation of purified protein ................................................... 100 2.9 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) ..... ........................................................................................................................ 100 2.9.1 Sample Preparation for SDS-PAGE ...................................................... 100 2.9.2 SDS-PAGE ............................................................................................ 100 2.9.3 Gel staining ............................................................................................ 101 2.10 Western blotting ............................................................................................. 101 2.10.1 Western transfer ................................................................................. 102 2.10.2 Immunoblotting and protein detection ............................................... 102 2.11 Antibodies ...................................................................................................... 104 2.12 Bioinformatics ................................................................................................ 106 3 Optimising conditions to evaluate the roles of multiple phosphorylation sites in eIF2B .................................................................................................................. 108 3.1 Background of current project ......................................................................
Recommended publications
  • Evolution of Translation EF-Tu: Trna
    University of Illinois at Urbana-Champaign Luthey-Schulten Group NIH Resource for Macromolecular Modeling and Bioinformatics Computational Biophysics Workshop Evolution of Translation EF-Tu: tRNA VMD Developer: John Stone MultiSeq Developers Tutorial Authors Elijah Roberts Ke Chen John Eargle John Eargle Dan Wright Zhaleh Ghaemi Jonathan Lai Zan Luthey-Schulten August 2014 A current version of this tutorial is available at http://www.scs.illinois.edu/~schulten/tutorials/ef-tu CONTENTS 2 Contents 1 Introduction 3 1.1 The Elongation Factor Tu . 3 1.2 Getting Started . 4 1.2.1 Requirements . 4 1.2.2 Copying the tutorial files . 4 1.2.3 Working directory . 4 1.2.4 Preferences . 4 1.3 Configuring BLAST for MultiSeq . 5 2 Comparative Analysis of EF-Tu 5 2.1 Finding archaeal EF1A sequences . 6 2.2 Aligning archaeal sequences and removing redundancy . 8 2.3 Finding bacteria EF-Tu sequences . 11 2.4 Performing ClustalW Multiple Sequence and Profile-Profile Align- ments . 12 2.5 Creating Multiple Sequence with MAFFT . 16 2.6 Conservation of EF-Tu among the Bacteria . 16 2.7 Finding conserved residues across the bacterial and archaeal do- mains . 20 2.8 EF-Tu Interface with the Ribosome . 21 3 Computing a Maximum Likelihood Phylogenetic Tree with RAxML 23 3.1 Load the Phylogenetic Tree into MultiSeq . 25 3.2 Reroot and Manipulate the Phylogenetic Tree . 25 4 MultiSeq TCL Scripting: Genomic Context 27 5 Appendix A 30 5.1 Building a BLAST Database . 30 6 Appendix B 31 6.1 Saving QR subset of alignments in PHYLIP and FASTA format 31 6.2 Calculating Maximum Likelihood Trees with RAxML .
    [Show full text]
  • Crystal Structure of the Eukaryotic 60S Ribosomal Subunit in Complex with Initiation Factor 6
    Research Collection Doctoral Thesis Crystal structure of the eukaryotic 60S ribosomal subunit in complex with initiation factor 6 Author(s): Voigts-Hoffmann, Felix Publication Date: 2012 Permanent Link: https://doi.org/10.3929/ethz-a-007303759 Rights / License: In Copyright - Non-Commercial Use Permitted This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library ETH Zurich Dissertation No. 20189 Crystal Structure of the Eukaryotic 60S Ribosomal Subunit in Complex with Initiation Factor 6 A dissertation submitted to ETH ZÜRICH for the degree of Doctor of Sciences (Dr. sc. ETH Zurich) presented by Felix Voigts-Hoffmann MSc Molecular Biotechnology, Universität Heidelberg born April 11, 1981 citizen of Göttingen, Germany accepted on recommendation of Prof. Dr. Nenad Ban (Examiner) Prof. Dr. Raimund Dutzler (Co-examiner) Prof. Dr. Rudolf Glockshuber (Co-examiner) 2012 blank page ii Summary Ribosomes are large complexes of several ribosomal RNAs and dozens of proteins, which catalyze the synthesis of proteins according to the sequence encoded in messenger RNA. Over the last decade, prokaryotic ribosome structures have provided the basis for a mechanistic understanding of protein synthesis. While the core functional centers are conserved in all kingdoms, eukaryotic ribosomes are much larger than archaeal or bacterial ribosomes. Eukaryotic ribosomal rRNA and proteins contain extensions or insertions to the prokaryotic core, and many eukaryotic proteins do not have prokaryotic counterparts. Furthermore, translation regulation and ribosome biogenesis is much more complex in eukaryotes, and defects in components of the translation machinery are associated with human diseases and cancer.
    [Show full text]
  • Eif2b Is a Decameric Guanine Nucleotide Exchange Factor with a G2e2 Tetrameric Core
    ARTICLE Received 19 Feb 2014 | Accepted 15 Apr 2014 | Published 23 May 2014 DOI: 10.1038/ncomms4902 OPEN eIF2B is a decameric guanine nucleotide exchange factor with a g2e2 tetrameric core Yuliya Gordiyenko1,2,*, Carla Schmidt1,*, Martin D. Jennings3, Dijana Matak-Vinkovic4, Graham D. Pavitt3 & Carol V. Robinson1 eIF2B facilitates and controls protein synthesis in eukaryotes by mediating guanine nucleotide exchange on its partner eIF2. We combined mass spectrometry (MS) with chemical cross- linking, surface accessibility measurements and homology modelling to define subunit stoichiometry and interactions within eIF2B and eIF2. Although it is generally accepted that eIF2B is a pentamer of five non-identical subunits (a–e), here we show that eIF2B is a decamer. MS and cross-linking of eIF2B complexes allows us to propose a model for the subunit arrangements within eIF2B where the subunit assembly occurs through catalytic g- and e-subunits, with regulatory subunits arranged in asymmetric trimers associated with the core. Cross-links between eIF2 and eIF2B allow modelling of interactions that contribute to nucleotide exchange and its control by eIF2 phosphorylation. Finally, we identify that GTP binds to eIF2Bg, prompting us to propose a multi-step mechanism for nucleotide exchange. 1 Department of Chemistry, Physical and Theoretical Chemistry Laboratory, University of Oxford, South Parks Road, Oxford OX1 3QZ, UK. 2 MRC Laboratory of Molecular Biology, University of Cambridge, Francis Crick Avenue, Cambridge CB2 0QH, UK. 3 Faculty of Life Sciences, Michael Smith Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK. 4 Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK.
    [Show full text]
  • Cofactor Dependent Conformational Switching of Gtpases
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector 1704 Biophysical Journal Volume 95 August 2008 1704–1715 Cofactor Dependent Conformational Switching of GTPases Vasili Hauryliuk,*y Sebastian Hansson,z and Ma˚ns Ehrenberg* *Department of Cell and Molecular Biology, Molecular Biology Program, Uppsala University, Uppsala, Sweden; yEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia; and zLaboratoire d’Enzymologie et Biochimie Structurales, CNRS, Avenue de la Terrasse, 91198 Gif-sur-Yvette, France ABSTRACT This theoretical work covers structural and biochemical aspects of nucleotide binding and GDP/GTP exchange of GTP hydrolases belonging to the family of small GTPases. Current models of GDP/GTP exchange regulation are often based on two specific assumptions. The first is that the conformation of a GTPase is switched by the exchange of the bound nucleotide from GDP to GTP or vice versa. The second is that GDP/GTP exchange is regulated by a guanine nucleotide exchange factor, which stabilizes a GTPase conformation with low nucleotide affinity. Since, however, recent biochemical and structural data seem to contradict this view, we present a generalized scheme for GTPase action. This novel ansatz accounts for those important cases when conformational switching in addition to guanine nucleotide exchange requires the presence of cofactors, and gives a more nuanced picture of how the nucleotide exchange is regulated. The scheme is also used to discuss some problems of interpretation that may arise when guanine nucleotide exchange mechanisms are inferred from experiments with analogs of GTP, like GDPNP, GDPCP, and GDP g S.
    [Show full text]
  • Effects of Oxidative Stress on Protein Translation
    International Journal of Molecular Sciences Review Effects of Oxidative Stress on Protein Translation: Implications for Cardiovascular Diseases Arnab Ghosh * and Natalia Shcherbik * Department for Cell Biology and Neuroscience, School of Osteopathic Medicine, Rowan University, 2 Medical Center Drive, Stratford, NJ 08084, USA * Correspondence: [email protected] (A.G.); [email protected] (N.S.); Tel.: +1-856-566-6907 (A.G.); +1-856-566-6914 (N.S.) Received: 24 March 2020; Accepted: 9 April 2020; Published: 11 April 2020 Abstract: Cardiovascular diseases (CVDs) are a group of disorders that affect the heart and blood vessels. Due to their multifactorial nature and wide variation, CVDs are the leading cause of death worldwide. Understanding the molecular alterations leading to the development of heart and vessel pathologies is crucial for successfully treating and preventing CVDs. One of the causative factors of CVD etiology and progression is acute oxidative stress, a toxic condition characterized by elevated intracellular levels of reactive oxygen species (ROS). Left unabated, ROS can damage virtually any cellular component and affect essential biological processes, including protein synthesis. Defective or insufficient protein translation results in production of faulty protein products and disturbances of protein homeostasis, thus promoting pathologies. The relationships between translational dysregulation, ROS, and cardiovascular disorders will be examined in this review. Keywords: protein translation; ribosome; RNA; IRES; uORF; miRNA; cardiovascular diseases; reactive oxygen species; oxidative stress; antioxidants 1. Introduction The process of protein synthesis, or protein translation, constitutes the last and final step of the central dogma of molecular biology: assembly of polypeptides based on the information encoded by mRNAs. This complex process employs multiple essential players, including ribosomes, mRNAs, tRNAs, and numerous translational factors, enzymes, and regulatory proteins.
    [Show full text]
  • Ef-G:Trna Dynamics During the Elongation Cycle of Protein Synthesis
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2015 Ef-G:trna Dynamics During the Elongation Cycle of Protein Synthesis Rong Shen University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Biochemistry Commons Recommended Citation Shen, Rong, "Ef-G:trna Dynamics During the Elongation Cycle of Protein Synthesis" (2015). Publicly Accessible Penn Dissertations. 1131. https://repository.upenn.edu/edissertations/1131 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1131 For more information, please contact [email protected]. Ef-G:trna Dynamics During the Elongation Cycle of Protein Synthesis Abstract During polypeptide elongation cycle, prokaryotic elongation factor G (EF-G) catalyzes the coupled translocations on the ribosome of mRNA and A- and P-site bound tRNAs. Continued progress has been achieved in understanding this key process, including results of structural, ensemble kinetic and single- molecule studies. However, most of work has been focused on the pre-equilibrium states of this fast process, leaving the real time dynamics, especially how EF-G interacts with the A-site tRNA in the pretranslocation complex, not fully elucidated. In this thesis, the kinetics of EF-G catalyzed translocation is investigated by both ensemble and single molecule fluorescence resonance energy transfer studies to further explore the underlying mechanism. In the ensemble work, EF-G mutants were designed and expressed successfully. The labeled EF-G mutants show good translocation activity in two different assays. In the smFRET work, by attachment of a fluorescent probe at position 693 on EF-G permits monitoring of FRET efficiencies to sites in both ribosomal protein L11 and A-site tRNA.
    [Show full text]
  • The Ribosomal Peptidyl Transferase Center: Structure, Function, Evolution, Inhibition
    Critical Reviews in Biochemistry and Molecular Biology, 40:285–311, 2005 Copyright c Taylor & Francis Inc. ! ISSN: 1040-9238 print / 1549-7798 online DOI: 10.1080/10409230500326334 The Ribosomal Peptidyl Transferase Center: Structure, Function, Evolution, Inhibition Norbert Polacek Innsbruck Biocenter, Division of ABSTRACT The ribosomal peptidyl transferase center (PTC) resides in the Genomics and RNomics, large ribosomal subunit and catalyzes the two principal chemical reactions of Innsbruck Medical University, protein synthesis: peptide bond formation and peptide release. The catalytic Innsbruck, Austria mechanisms employed and their inhibition by antibiotics have been in the Alexander S. Mankin focus of molecular and structural biologists for decades. With the elucidation Center for Pharmaceutical of atomic structures of the large ribosomal subunit at the dawn of the new Biotechnology, University of millennium, these questions gained a new level of molecular significance. The Illinois at Chicago, Chicago, crystallographic structures compellingly confirmed that peptidyl transferase is IL 60607, USA an RNA enzyme. This places the ribosome on the list of naturally occurring riboyzmes that outlived the transition from the pre-biotic RNA World to con- temporary biology. Biochemical, genetic and structural evidence highlight the role of the ribosome as an entropic catalyst that accelerates peptide bond for- mation primarily by substrate positioning. At the same time, peptide release should more strongly depend on chemical catalysis likely involving an rRNA group of the PTC. The PTC is characterized by the most pronounced accu- mulation of universally conserved rRNA nucleotides in the entire ribosome. Thus, it came as a surprise that recent findings revealed an unexpected high level of variation in the mode of antibiotic binding to the PTC of ribosomes from different organisms.
    [Show full text]
  • Mitochondrial Translation and Its Impact on Protein Homeostasis And
    Mitochondrial translation and its impact on protein homeostasis and aging Tamara Suhm Academic dissertation for the Degree of Doctor of Philosophy in Biochemistry at Stockholm University to be publicly defended on Friday 15 February 2019 at 09.00 in Magnélisalen, Kemiska övningslaboratoriet, Svante Arrhenius väg 16 B. Abstract Besides their famous role as powerhouse of the cell, mitochondria are also involved in many signaling processes and metabolism. Therefore, it is unsurprising that mitochondria are no isolated organelles but are in constant crosstalk with other parts of the cell. Due to the endosymbiotic origin of mitochondria, they still contain their own genome and gene expression machinery. The mitochondrial genome of yeast encodes eight proteins whereof seven are core subunits of the respiratory chain and ATP synthase. These subunits need to be assembled with subunits imported from the cytosol to ensure energy supply of the cell. Hence, coordination, timing and accuracy of mitochondrial gene expression is crucial for cellular energy production and homeostasis. Despite the central role of mitochondrial translation surprisingly little is known about the molecular mechanisms. In this work, I used baker’s yeast Saccharomyces cerevisiae to study different aspects of mitochondrial translation. Exploiting the unique possibility to make directed modifications in the mitochondrial genome of yeast, I established a mitochondrial encoded GFP reporter. This reporter allows monitoring of mitochondrial translation with different detection methods and enables more detailed studies focusing on timing and regulation of mitochondrial translation. Furthermore, employing insights gained from bacterial translation, we showed that mitochondrial translation efficiency directly impacts on protein homeostasis of the cytoplasm and lifespan by affecting stress handling.
    [Show full text]
  • A Dissertation Entitled Characterization of the CXCR4
    A Dissertation entitled Characterization of the CXCR4-LASP1-eIF4F Axis in Triple-Negative Breast Cancer by Cory M Howard Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Biomedical Sciences ___________________________________________ Dayanidhi Raman, B.V.Sc., Ph.D., Committee Chair ___________________________________________ Amit Tiwari, Ph.D., Committee Member ___________________________________________ Ritu Chakravarti, Ph.D., Committee Member ___________________________________________ Nagalakshmi Nadiminty, Ph.D., Committee Member ___________________________________________ Saori Furuta, Ph.D., Committee Member ___________________________________________ Shi-He Liu, M.D., Committee Member ___________________________________________ Amanda C. Bryant-Friedrich, Ph.D., Dean College of Graduate Studies The University of Toledo August 2020 © 2020 Cory M. Howard This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Characterization of the CXCR4-LASP1-eIF4F Axis in Triple-Negative Breast Cancer by Cory M. Howard Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Biomedical Sciences The University of Toledo August 2020 Triple-negative breast cancer (TNBC) remains clinically challenging as effective targeted therapies are still lacking. In addition, patient mortality mainly results from the metastasized
    [Show full text]
  • Peptidyl-Transferase Ribozymes: Trans Reactions, Structural Characterization and Ribosomal RNA-Like Features Wang Zhang* and Thomas R Cech
    Research Paper 539 Peptidyl-transferase ribozymes: trans reactions, structural characterization and ribosomal RNA-like features Wang Zhang* and Thomas R Cech Background: One of the most significant questions in understanding the origin Address: Howard Hughes Medical Institute, of life concerns the order of appearance of DNA, RNA and protein during early Department of Chemistry and Biochemistry, University of Colorado, Boulder, CO 80309-0215, biological evolution. If an ‘RNA world’ was a precursor to extant life, RNA must USA. be able not only to catalyze RNA replication but also to direct peptide synthesis. Iterative RNA selection previously identified catalytic RNAs (ribozymes) that form *Present address: Program in Molecular Medicine, amide bonds between RNA and an amino acid or between two amino acids. University of Massachusetts Medical Center, 373 Plantation Street, Worcester, MA 01605, USA. Results: We characterized peptidyl-transferase reactions catalyzed by two Correspondence: Thomas R Cech different families of ribozymes that use substrates that mimic A site and P site E-mail: [email protected] tRNAs. The family II ribozyme secondary structure was modeled using chemical Key words: metal ions, peptidyl transferase, modification, enzymatic digestion and mutational analysis. Two regions ribosomal RNA structure, RNA catalysis, RNA resemble the peptidyl-transferase region of 23s ribosomal RNA in sequence structure and structural context; these regions are important for peptide-bond formation. A shortened form of this ribozyme was engineered to catalyze intermolecular Received: 3 August 1998 (‘trans’) peptide-bond formation, with the two amino-acid substrates binding Revisions requested: 18 August 1998 Revisions received: 26 August 1998 through an attached AMP or oligonucleotide moiety.
    [Show full text]
  • ANA-1 Murine Macrophages Ribosomal Peptidyl Transferase Activity in Cleavage Is Associated with Inhibition of Nitric Oxide-Depen
    Nitric Oxide-Dependent Ribosomal RNA Cleavage Is Associated with Inhibition of Ribosomal Peptidyl Transferase Activity in ANA-1 Murine Macrophages This information is current as of October 2, 2021. Charles Q. Cai, Hongtao Guo, Rebecca A. Schroeder, Cecile Punzalan and Paul C. Kuo J Immunol 2000; 165:3978-3984; ; doi: 10.4049/jimmunol.165.7.3978 http://www.jimmunol.org/content/165/7/3978 Downloaded from References This article cites 13 articles, 5 of which you can access for free at: http://www.jimmunol.org/content/165/7/3978.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on October 2, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2000 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Nitric Oxide-Dependent Ribosomal RNA Cleavage Is Associated with Inhibition of Ribosomal Peptidyl Transferase Activity in ANA-1 Murine Macrophages1 Charles Q. Cai,* Hongtao Guo,* Rebecca A. Schroeder,† Cecile Punzalan,* Paul C. Kuo2* NO can regulate specific cellular functions by altering transcriptional programs and protein reactivity.
    [Show full text]
  • Nck Adapter Proteins: Functional Versatility in T Cells Marcus Lettau, Jennifer Pieper and Ottmar Janssen
    Cell Communication and Signaling BioMed Central Review Open Access Nck adapter proteins: functional versatility in T cells Marcus Lettau, Jennifer Pieper and Ottmar Janssen Address: 1University Hospital Schleswig-Holstein Campus Kiel, Institute of Immunology, Molecular Immunology, Arnold-Heller-Str 3, Bldg 17, D-24105 Kiel, Germany E-mail: Marcus Lettau* - [email protected]; Jennifer Pieper - [email protected]; Ottmar Janssen - [email protected] *Corresponding author Published: 02 February 2009 Received: 2 December 2008 Cell Communication and Signaling 2009, 7:1 doi: 10.1186/1478-811X-7-1 Accepted: 2 February 2009 This article is available from: http://www.biosignaling.com/content/7/1/1 © 2009 Lettau et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Nck is a ubiquitously expressed adapter protein that is almost exclusively built of one SH2 domain and three SH3 domains. The two isoproteins of Nck are functionally redundant in many aspects and differ in only few amino acids that are mostly located in the linker regions between the interaction modules. Nck proteins connect receptor and non-receptor tyrosine kinases to the machinery of actin reorganisation. Thereby, Nck regulates activation-dependent processes during cell polarisation and migration and plays a crucial role in the signal transduction of a variety of receptors including for instance PDGF-, HGF-, VEGF- and Ephrin receptors. In most cases, the SH2 domain mediates binding to the phosphorylated receptor or associated phosphoproteins, while SH3domaininteractionsleadtotheformationoflargerproteincomplexes.InTlymphocytes,Nck plays a pivotal role in the T cell receptor (TCR)-induced reorganisation of the actin cytoskeleton and the formation of the immunological synapse.
    [Show full text]